274
Participants
Start Date
August 31, 2005
Primary Completion Date
November 30, 2008
Study Completion Date
January 31, 2009
AZLI 75 mg two times a day (BID)/ three times a day (TID)
Birmingham
Anchorage
Phoenix
Little Rock
La Jolla
Los Angeles
Oakland
Orange
Denver
Hartford
New Haven
Jacksonville
Orlando
Atlanta
Augusta
Chicago
Glenview
Maywood
Park Ridge
Indianapolis
Wichita
Shreveport
Boston
Ann Arbor
Detroit
Minneapolis
Columbia
St Louis
Las Vegas
Livingston
Morristown
Albany
Brooklyn
Buffalo
New Hyde Park
New York
Syracuse
Valhalla
Chapel Hill
Akron
Cincinnati
Columbus
Dayton
Oklahoma City
Hershey
Philadelphia
Pittsburgh
Charleston
Columbia
Houston
San Antonio
Salt Lake City
Portsmouth
Richmond
Seattle
Morgantown
Westmead
Herston
Adelaide
Prahan
Nedlands
Perth
Edmonton
London
Auckland
Lead Sponsor
Gilead Sciences
INDUSTRY